MedPath

Effect of Iranian Xenograft for horizontal augmentation in edentulous ridge

Phase 3
Conditions
Patients with severe alveolar ridge resorption.
Registration Number
IRCT20240130060865N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients over 18 years old
Have at least one toothless area with a ridge width of less than 5 mm

Exclusion Criteria

Pregnancy
Uncontrolled Systemic disease
Taking medications that interfere with bone healing

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alveolar ridge horizontal augmentation. Timepoint: Before the study and 24 months after the treatment. Method of measurement: Cone beam computed tomography (CBCT) scans.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath